Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

Iyer, Gopa

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 07 2018 - 1949-1956 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2017.75.0158 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Chemotherapy, Adjuvant
Cisplatin--administration & dosage
Cystectomy
Deoxycytidine--administration & dosage
Disease-Free Survival
Female
Filgrastim--administration & dosage
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Invasiveness
Neoplasm Recurrence, Local--diagnostic imaging
Neoplasm Staging
Polyethylene Glycols--administration & dosage
Prospective Studies
Urinary Bladder Neoplasms--diagnostic imaging
Gemcitabine